CORRECTION : JP Morgan Maintains Overweight on Qiagen, Raises Price Target to $54 -Analyst Name Updated (Article Originally Published on 18th June)
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Casey Woodring maintains an Overweight rating on Qiagen (NYSE:QGEN) and raises the price target from $52 to $54.
June 21, 2024 | 1:58 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JP Morgan analyst Casey Woodring maintains an Overweight rating on Qiagen and raises the price target from $52 to $54.
The raised price target and maintained Overweight rating from a reputable analyst at JP Morgan is likely to positively influence investor sentiment and drive short-term price appreciation for Qiagen.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100